9
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: A global analysis

      research-article
      Environmental Research
      Published by Elsevier Inc.
      COVID-19 vaccine, Vaccination campaign, Public health, Herd immunity, Crisis management

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Coronavirus disease 2019 (COVID-19) continues to be a pandemic threat that is generating a constant state of alert in manifold countries. One of the strategies of defense against infectious diseases is the vaccinations that decrease the numbers of COVID-19 related infected individuals and deaths. In this context, the optimal level of vaccination is a basic point to control pandemic crisis. The study here,−using global data of doses of vaccines administered per 100 inhabitants, confirmed cases and case fatality ratio of COVID-19 between countries from March to May 2021,− clarifies the optimal levels of vaccination for reducing the number of infected individuals and, consequently, numbers of deaths. Findings reveal that the average level of administering about 80 doses of vaccines per 100 inhabitants between countries can sustain a reduction of confirmed cases and numbers of deaths. In addition, results suggest that an intensive vaccination campaign in the initial phase of pandemic wave leads to a lower optimal level of doses administered per 100 inhabitants (roughly 47 doses of vaccines) for reducing infected individuals; however, the growth of pandemic wave moves up the optimal level of vaccines to about 90 doses for reducing the numbers of COVID-19 related infected individuals. All these results here could aid policymakers to prepare optimal strategies directed to a rapid COVID-19 vaccination rollout, before the takeoff of pandemic wave, to lessen negative effects of pandemic crisis on environment and socioeconomic systems.

          Related collections

          Most cited references73

          • Record: found
          • Abstract: found
          • Article: not found

          Immunological considerations for COVID-19 vaccine strategies

          The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to humanity in a century. It is widely believed that prepandemic normalcy will never return until a safe and effective vaccine strategy becomes available and a global vaccination programme is implemented successfully. Here, we discuss the immunological principles that need to be taken into consideration in the development of COVID-19 vaccine strategies. On the basis of these principles, we examine the current COVID-19 vaccine candidates, their strengths and potential shortfalls, and make inferences about their chances of success. Finally, we discuss the scientific and practical challenges that will be faced in the process of developing a successful vaccine and the ways in which COVID-19 vaccine strategies may evolve over the next few years.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Herd Immunity: Understanding COVID-19

            The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has demonstrated the devastating impact of a novel, infectious pathogen on a susceptible population. Here, we explain the basic concepts of herd immunity and discuss its implications in the context of COVID-19.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Planning for a COVID-19 Vaccination Program

                Bookmark

                Author and article information

                Journal
                Environ Res
                Environ Res
                Environmental Research
                Published by Elsevier Inc.
                0013-9351
                1096-0953
                2 November 2021
                2 November 2021
                : 112314
                Affiliations
                [1]CNR -- National Research Council of Italy, Collegio Carlo Alberto, Via Real Collegio, n. 30, 10024, Moncalieri, TO, Italy
                Article
                S0013-9351(21)01615-7 112314
                10.1016/j.envres.2021.112314
                8560189
                34736923
                12c61775-effb-4ea1-bae9-b11d71b409cb
                © 2021 Published by Elsevier Inc.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 17 June 2021
                : 26 October 2021
                : 28 October 2021
                Categories
                Article

                General environmental science
                covid-19 vaccine,vaccination campaign,public health,herd immunity,crisis management

                Comments

                Comment on this article